Ontology highlight
ABSTRACT: Objective
We sought to evaluate early clinical differences between cerebral arteriolosclerosis (pARTE), Alzheimer disease (pAD), and AD with arteriolosclerosis (ADARTE).Methods
Using National Alzheimer's Coordinating Center neuropathology diagnoses, we defined pARTE (n=21), pAD (n=203), and ADARTE (n=158) groups. We compared demographics, medical history, psychometrics, neuropsychiatric symptoms, and apolipoprotein E (APOE) allele variants across neuropathology groups. Retrospective timepoints were first evaluation with Global Clinical Dementia Rating (CDR) score of 0.5 and 1.0, via the CDR Dementia Staging Instrument, corresponding to mild cognitive impairment (MCI) and mild dementia, respectively.Results
In MCI, clinical differences were minimal but pARTE subjects
SUBMITTER: Yang D
PROVIDER: S-EPMC7904566 | biostudies-literature | 2021 Jan-Mar 01
REPOSITORIES: biostudies-literature